期刊
JOURNAL OF PSYCHOPHARMACOLOGY
卷 26, 期 7, 页码 899-952出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881112444324
关键词
Substance misuse; addiction; guidelines; pharmacotherapy; comorbidity
资金
- MRC [G1002226] Funding Source: UKRI
- Cancer Research UK [14135] Funding Source: researchfish
- Medical Research Council [G1002226] Funding Source: researchfish
The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback from participants. The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据